262) ro assays, this study shows for the first time a role for Trp75 as a channel entranc |
263) pplications has been discovered over this time, a number of issues remain. |
264) Time-use data were mainly collected using |
265) d (e.g., focusing on accuracy or response time data only). |
266) compared to a regression-based models on time-updated data. |
267) ave daily seizures at least for a limited time during early childhood, and two-third |
268) 4 days after last drink) and a second time during extended abstinence (n = 1 |
269) Analysis of HSC-LCs at multiple time-points during differentiation reveale |
270) The articles were filtered by a ten-year time frame (2010-2019) and a strict inclus |
271) from the same population within the same time frame were characterized with routine |
272) Therefore, literature searches without a time frame were conducted on several datab |
273) andardized outcome measures and follow-up time frames are needed across contexts to |
274) study revealed no differences in recovery time frames or overall symptom burden. |
275) ssessment methods, outcomes, and recovery time frames. |
276) ns differed, among others, in the covered time horizon (referring either only to emp |
277) Most of these studies had a minimum time horizon of 10 years. |
278) that conducted long-term projections, the time horizon of the projection was an aver |
279) P450 3A (CYP3A) is a frequent target for time-dependent inhibition (TDI) that can g |
280) However, time-dependent inhibition of CYP2C8 by can |
281) age, we performed in vitro metabolism and time-dependent inhibition studies for soli |
282) tation, allowing physicians to spend less time on EHR engagement and more time with |
283) Minor negative aspects included increased time on task, overwhelming learning conten |
284) Median overall time on treatment (afatinib and osimertini |
285) For the first time, we demonstrated robustness and effic |
286) Here, for the first time, we examined the behavioral performan |
287) Here, for the first time, we have examined the acute response |
288) ems (macOS and Windows 10) impact display time across 30 different frame durations f |
289) e results were not always maintained over time across studies. |
290) , but how the route of administration and time after dosing affects maternal-fetal d |
291) ing were prospectively recruited at three time-points after SAH: within the first 72 |
292) sing response, fast response and recovery time along with acceptable selectivity tow |
293) A shift to maximising on-scene treatment time, along with bundling novel prehospita |
294) Longer time between LT and ISW was the only clini |
|